TECH
BIO-TECHNE Corp
NASDAQ · Healthcare · Biotechnology · US
$72.37
−0.06%Forward multiples
Based on analyst estimates
- P/E forward
- 35.26x
- P/E 2026E
- —
- P/E 2027E
- 35.19x
- P/E 2028E
- 30.91x
- P/S forward
- 8.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- 61.85x
- PEG TTM
- 0.82x
- Price / book
- 5.38x
- Price / sales
- 9.34x
- Price / cash flow
- 38.86x
Enterprise value
- Enterprise value
- $11.4B
- EV / sales
- 9.36x
- EV / EBITDA
- 33.12x
- EV / EBIT
- 45.15x
- Market cap
- $11.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026